Lichen sclerosus is not contagious. You cannot catch it from another person or pass it to a partner through sexual contact, skin-to-skin touch, or any other form of transmission. It is a chronic inflammatory skin condition driven by the immune system, not by any virus, bacterium, or fungus that can spread between people.
Why It Cannot Be Spread
Lichen sclerosus is classified as an autoimmune condition, meaning the body’s own immune system mistakenly attacks healthy skin tissue. This produces the characteristic white, thinned patches that appear most often in the genital and anal area. Because the underlying problem is an internal immune response rather than an outside infection, there is no mechanism for the condition to transfer from one person to another.
The confusion is understandable. Lichen sclerosus often appears on the genitals, can cause visible skin changes, and sometimes produces symptoms that overlap with sexually transmitted infections, like itching, soreness, and skin cracking. But a partner of someone with lichen sclerosus faces zero risk of developing the condition from contact.
What Actually Causes It
The exact cause remains unclear, but research points to several overlapping factors. The strongest evidence supports an autoimmune origin. Roughly 74 to 80% of women with genital lichen sclerosus produce specific antibodies against a protein in their own skin called extracellular matrix protein 1. These antibodies attack the structural framework of the skin, leading to inflammation, thinning, and scarring over time.
Genetics play a role as well. About 12% of people with lichen sclerosus have a family history of the condition, and specific immune system gene variants increase susceptibility. The condition also frequently co-occurs with other autoimmune diseases, including thyroid disease, vitiligo, alopecia areata, and pernicious anemia. Detectable anti-thyroid antibodies show up in 11 to 40% of women with lichen sclerosus, a rate well above the general population.
Hormonal factors likely contribute too. The condition disproportionately affects postmenopausal women and prepubertal children, both groups with lower estrogen levels. However, hormone replacement therapy does not improve existing disease or prevent it, so estrogen deficiency alone is not the full explanation. The current understanding is that lichen sclerosus results from a combination of genetic predisposition, immune dysfunction, and possibly hormonal shifts or skin trauma that triggers flares (a phenomenon known as the Koebner response, where skin conditions appear at sites of injury or friction).
Who Gets It
Lichen sclerosus is most common in postmenopausal women, with prevalence estimates ranging from 1 in 1,000 to as high as 1 in 60. Men develop it far less frequently, at a ratio of roughly 1 man for every 6 to 10 women affected. Children can also develop the condition: the estimated prevalence in girls aged 2 to 16 is about 1 in 900, while boys aged 0 to 14 have a higher incidence of roughly 1 in 200.
Recognizing the Symptoms
Early lichen sclerosus often starts as mild redness in the genital or anal area, which can be easy to overlook or mistake for irritation. As the condition progresses, the skin develops white, shiny patches with a thin, crinkled texture sometimes described as looking like cellophane paper. Itching is the hallmark symptom and can be intense.
More advanced disease can produce skin cracking (fissures), small areas of bruising or bleeding under the skin, and thickened white plaques. In women, a characteristic figure-of-eight pattern may develop around the vulva and anus. Over time, scarring can shrink the labia minora, bury the clitoris, or narrow the vaginal opening. In men, the foreskin and head of the penis are most commonly affected, and tightening of the foreskin is a frequent complication. Children, especially girls, may first notice slight redness followed by loss of skin color.
Lichen sclerosus can also appear on other parts of the body (chest, upper arms, back), though this is less common. When it occurs outside the genital area, small plugs of keratin in hair follicles are a distinguishing feature.
How It Is Diagnosed
An experienced clinician can often diagnose lichen sclerosus by its appearance alone. White skin changes in the genital area paired with itching are highly suggestive. When the presentation is unclear, a small skin biopsy (typically 5 mm) from a white, intact area of skin confirms the diagnosis. Biopsies are taken from characteristic patches, not from ulcerated or cracked areas, since those can give misleading results. Early lesions may look nonspecific under the microscope, so biopsies of more established patches are more reliable.
Treatment and Long-Term Management
The standard first-line treatment is a strong prescription steroid ointment applied directly to the affected skin. Treatment typically starts with twice-daily application for several weeks. Once the inflammation is controlled, the frequency drops to about twice a week for ongoing maintenance. Most people see significant improvement in itching and skin texture with consistent use. Lichen sclerosus is a chronic condition, so maintenance treatment is usually long-term rather than a one-time course.
Day-to-day management focuses on reducing irritation. Soap, scented products, bubble baths, and shower gels can all worsen symptoms, so switching to a fragrance-free emollient cleanser is recommended. Urine contact can irritate affected skin, so drying carefully after using the toilet helps. Panty liners and incontinence pads can aggravate symptoms if used regularly. Cotton underwear and loose clothing reduce friction, which is important because skin trauma can trigger new patches or worsen existing ones.
Cancer Risk in Perspective
One of the more concerning aspects of lichen sclerosus is a small but real increased risk of squamous cell carcinoma at the affected site. A systematic review found that the risk varies between 0.21% and 3.88% in women and 0.00% to 0.91% in men. This means the vast majority of people with lichen sclerosus will never develop cancer, but regular monitoring matters. Any new lumps, non-healing sores, or changes in the texture or color of existing patches warrant prompt evaluation. Smoking increases the risk, and stopping smoking is one modifiable step that can help.
Consistent treatment with steroid ointment appears to reduce this risk, which is another reason long-term maintenance therapy is encouraged even when symptoms are well controlled.